These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 2131602)

  • 1. [Design of a vaccination campaign against hepatitis b virus].
    Canga A; Sanchez M; Fernandez E; Martinez J; Arcos P; Suarez MT
    Rev Sanid Hig Publica (Madr); 1990; 64(3-4):211-7. PubMed ID: 2131602
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Prevalence of hepatitis B markers in non-hospital health personnel].
    Devesa F; Martínez F; Moreno MJ; Gilabert M
    Rev Esp Enferm Dig; 1992 Aug; 82(2):96-9. PubMed ID: 1389556
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Vaccination and serologic markers of hepatitis B virus infection].
    Salmeron Garcia F; Echevarria Mayo JM
    Rev Sanid Hig Publica (Madr); 1990; 64(3-4):141-50. PubMed ID: 2131596
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Atypical profile of markers of hepatitis B and vaccination].
    Velosa J
    Acta Med Port; 1996; 9(7-9):247-51. PubMed ID: 9005705
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vaccination against hepatitis B in a general hospital in Israel: antibody level before vaccination and immunogenicity of vaccine.
    Karpuch J; Scapa E; Eshchar J; Waron M; Bar-Shany S; Shwartz T
    Isr J Med Sci; 1993 Aug; 29(8):449-52. PubMed ID: 8407270
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Anti-Hbs level after the basic course of vaccination against hepatitis B in health care workers].
    Tomasiewicz K; Modrzewska R; Lyczak A; Rzeszowska G
    Przegl Epidemiol; 1994; 48(1-2):11-5. PubMed ID: 8073126
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Seroepidemiology of hepatitis B virus markers among hospital health care workers. Analysis of certain potential risk factors.
    Daw MA; Siala IM; Warfalli MM; Muftah MI
    Saudi Med J; 2000 Dec; 21(12):1157-60. PubMed ID: 11360090
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepatitis B virus serologic markers and anti-hepatitis B vaccination in patients with diabetes.
    Halota W; Muszyńska M; Pawłowska M
    Med Sci Monit; 2002 Jul; 8(7):CR516-9. PubMed ID: 12118201
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Transient blood surface antigens of hepatitis B in patients on hemodialysis].
    Santana Rodríguez OE; Morillas Jarillo C; Esparza Martín N; Toledo González A; Checa Andrés MD; Martín Sánchez AM
    Rev Clin Esp; 1999 Apr; 199(4):198-201. PubMed ID: 10364790
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term efficacy of hepatitis B vaccination in healthcare workers of Oil Company Hospital, Tehran, Iran (1989-2005).
    Alavian SM; Mansouri S; Abouzari M; Assari S; Bonab MS; Miri SM
    Eur J Gastroenterol Hepatol; 2008 Feb; 20(2):131-4. PubMed ID: 18188034
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The serologic markers of hepatitis B virus infection--proper selection and standardized interpretation.
    Caspari G; Gerlich WH
    Clin Lab; 2007; 53(5-6):335-43, 391-400. PubMed ID: 17605409
    [No Abstract]   [Full Text] [Related]  

  • 12. [Field trial of the Cuban recombinant vaccine against hepatitis B (Heberbiovac HB). Study in newborn infants born to AgsHB+ mothers].
    Galbán García E; Bravo González JR; Castañeda Guillot C; Toledo Curbelo G; González Griego A; Delgado González MG
    Rev Cubana Med Trop; 1992; 44(2):149-57. PubMed ID: 9768208
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Study of hepatitis B (HB) vaccine non-responsiveness among health care workers from an endemic area (Taiwan).
    Yen YH; Chen CH; Wang JH; Lee CM; Changchien CS; Lu SN
    Liver Int; 2005 Dec; 25(6):1162-8. PubMed ID: 16343067
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Vaccination against hepatitis B: 3 years' experience at the Latium Operative Unit].
    Perroni L; Mattioli R; Ensoli G; Albertoni F; Duchini B; Ungaro P; Corsi T
    Ann Ig; 1989; 1(6):1307-15. PubMed ID: 2484467
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Evaluation on efficacy of plasma-derived hepatitis B vaccine and persistence of protective level after vaccination].
    Wang S; Wu C; Li Y
    Zhonghua Liu Xing Bing Xue Za Zhi; 1994 Jun; 15(3):154-7. PubMed ID: 7834691
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Evaluation of vaccine potency against viral hepatitis B performed with HB-vax II vaccine in a group with an increased risk for hepatitis B].
    Leśnik J; Cieślak A; Krychniak E; Sitkiewicz D
    Pol Merkur Lekarski; 1996 Oct; 1(4):249-51. PubMed ID: 9156936
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Low levels of awareness, vaccine coverage, and the need for boosters among health care workers in tertiary care hospitals in India.
    Sukriti ; Pati NT; Sethi A; Agrawal K; Agrawal K; Kumar GT; Kumar M; Kaanan AT; Sarin SK
    J Gastroenterol Hepatol; 2008 Nov; 23(11):1710-5. PubMed ID: 18761556
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Occupational exposure to hepatitis B virus in hospital personnel at the Naval Medical Center "Cirujano Mayor Santiago Távara"].
    Mejía Aliaga P
    Rev Gastroenterol Peru; 1993; 13(1):20-7. PubMed ID: 8219098
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Humoral immunity level and factors associated with the response to the vaccine against the hepatitis B virus in health personnel of the Case-Essalud National Hospital, Arequipa September 1995-March 2002].
    Campos Nizama J
    Rev Gastroenterol Peru; 2005; 25(2):141-9. PubMed ID: 16021199
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Seroprevalence of antibodies against hepatitis A virus and hepatitis B virus in nonvaccinated adult population over 40 years of age].
    Chlíbek R; Cecetková B; Smetana J; Prymula R; Kohl I
    Epidemiol Mikrobiol Imunol; 2006 Aug; 55(3):99-104. PubMed ID: 16970073
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.